Beijing’s Genetron Health, a precision medicine oncology company, raised over $61M in a Series C round led by Zhongjin Kangrui Medical Industrial Fund.
January 5, 2017 -- Beijing’s Genetron Health, a precision medicine oncology company, raised over $61 million in a Series C round led by Zhongjin Kangrui Medical Industrial Fund. Founded in 2013, Genetron offers molecular clinical services and professional cancer genetic risk assessment, covering full-cycle cancer clinical treatment. The company has R&D centers in North Carolina and Beijing, plus clinical medical testing centers in Beijing, Shanghai and Hangzhou.
